Elevated serum levels of leukocyte cell-derived chemotaxin 2 are associated with the prevalence of metabolic syndrome
ConclusionsIncreased LECT2 levels were significantly and independently associated with the presence and severity of MetS, indicating that LECT2 could be used as a novel biomarker and clinical predictor of MetS.Graphical abstract
Source: Acta Diabetologica - Category: Endocrinology Source Type: research
More News: Cholesterol | Diabetes | Diabetes Mellitus | Diets | Eating Disorders & Weight Management | Endocrinology | Genetics | High Fat | Hypertension | Liver | Metabolic Syndrome | Nutrition | Obesity | Smokers | Urology & Nephrology